<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31533043</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>A High-Content Screen Identifies TPP1 and Aurora B as Regulators of Axonal Mitochondrial Transport.</ArticleTitle><Pagination><StartPage>3224</StartPage><EndPage>3237.e5</EndPage><MedlinePgn>3224-3237.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2019.08.035</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(19)31075-7</ELocationID><Abstract><AbstractText>Dysregulated axonal trafficking of mitochondria is linked to neurodegenerative disorders. We report a high-content screen for small-molecule regulators of the axonal transport of mitochondria. Six compounds enhanced mitochondrial transport in the sub-micromolar range, acting via three cellular targets: F-actin, Tripeptidyl peptidase 1 (TPP1), or Aurora Kinase B (AurKB). Pharmacological inhibition or small hairpin RNA (shRNA) knockdown of each target promotes mitochondrial axonal transport in rat hippocampal neurons and induced pluripotent stem cell (iPSC)-derived human cortical neurons and enhances mitochondrial transport in iPSC-derived motor neurons from an amyotrophic lateral sclerosis (ALS) patient bearing one copy of SOD1<sup>A4V</sup> mutation. Our work identifies druggable regulators of axonal transport of mitochondria, provides broadly applicable methods for similar image-based screens, and suggests that restoration of proper axonal trafficking of mitochondria can be achieved in human ALS neurons.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shlevkov</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basu</LastName><ForeName>Himanish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bray</LastName><ForeName>Mark-Anthony</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Imaging Platform, Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apaydin</LastName><ForeName>Kaan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karhohs</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Imaging Platform, Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Pin-Fang</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Translational Neuroscience Center, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Janell L M</ForeName><Initials>JLM</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiskow</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roet</LastName><ForeName>Kasper</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggan</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carpenter</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Imaging Platform, Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleiman</LastName><ForeName>Robin J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Translational Neuroscience Center, Boston Children's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarz</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: thomas.schwarz@childrens.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM069808</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM122547</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HD090255</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000717268">Tpp1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000717269">Tpp1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000091346">Tripeptidyl-Peptidase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606292">Sod1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C576921">AURKB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C576924">Aurkb protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C576925">Aurkb protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D064107">Aurora Kinase B</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D057057">Serine Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.11.-</RegistryNumber><NameOfSubstance UI="D000626">Aminopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.14.-</RegistryNumber><NameOfSubstance UI="D004152">Dipeptidyl-Peptidases and Tripeptidyl-Peptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.14.9</RegistryNumber><NameOfSubstance UI="C000717267">TPP1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000626" MajorTopicYN="N">Aminopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064107" MajorTopicYN="N">Aurora Kinase B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001693" MajorTopicYN="N">Biological Transport, Active</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004152" MajorTopicYN="N">Dipeptidyl-Peptidases and Tripeptidyl-Peptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057057" MajorTopicYN="N">Serine Proteases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091346" MajorTopicYN="N">Tripeptidyl-Peptidase 1</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Aurora B</Keyword><Keyword MajorTopicYN="N">F-actin</Keyword><Keyword MajorTopicYN="N">TPP1</Keyword><Keyword MajorTopicYN="N">axonal transport</Keyword><Keyword MajorTopicYN="N">high-content screening</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword></KeywordList><CoiStatement>DECLARATION OF INTERESTS. M.-A.B. is an employee and shareholder of Novartis. K.K. is an employee and shareholder of Wayfair. J.L.M.S. is an employee and shareholder of Regeneron. O.W. is an employee and shareholder of Amgen. K.R. is an employee and shareholder of Quralis. K.E. is founder of Q-State and Quralis and a member of their scientific advisory boards.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31533043</ArticleId><ArticleId IdType="mid">NIHMS1542901</ArticleId><ArticleId IdType="pmc">PMC6937139</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2019.08.035</ArticleId><ArticleId IdType="pii">S2211-1247(19)31075-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Basarsky TA, Parpura V, and Haydon PG (1994). Hippocampal synaptogenesis in cell culture: developmental time course of synapse formation, calcium influx, and synaptic protein distribution. J. Neurosci 14, 6402&#x2013;6411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6577282</ArticleId><ArticleId IdType="pubmed">7965045</ArticleId></ArticleIdList></Reference><Reference><Citation>Carboni JM, Wittman M, Yang Z, Lee F, Greer A, Hurlburt W, Hillerman S, Cao C, Cantor GH, Dell-John J, et al. (2009). BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR. Mol. Cancer Ther 8, 3341&#x2013;3349.</Citation><ArticleIdList><ArticleId IdType="pubmed">19996272</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, et al. (2006). CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1794559</ArticleId><ArticleId IdType="pubmed">17076895</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartoni R, Norsworthy MW, Bei F, Wang C, Li S, Zhang Y, Gabel CV, Schwarz TL, and He Z (2016). The Mammalian-Specific Protein Armcx1 Regulates Mitochondrial Transport during Axon Regeneration. Neuron 92, 1294&#x2013;1307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5189716</ArticleId><ArticleId IdType="pubmed">28009275</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartoni R, Pekkurnaz G, Wang C, Schwarz TL, and He Z (2017). A high mitochondrial transport rate characterizes CNS neurons with high axonal regeneration capacity. PLoS ONE 12, e0184672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5604968</ArticleId><ArticleId IdType="pubmed">28926622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chada SR, and Hollenbeck PJ (2003). Mitochondrial movement and positioning in axons: the role of growth factor signaling. J. Exp. Biol 206, 1985&#x2013;1992.</Citation><ArticleIdList><ArticleId IdType="pubmed">12756280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chada SR, and Hollenbeck PJ (2004). Nerve growth factor signaling regulates motility and docking of axonal mitochondria. Curr. Biol 14, 1272&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pubmed">15268858</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang DT, Honick AS, and Reynolds IJ (2006). Mitochondrial trafficking to synapses in cultured primary cortical neurons. J. Neurosci 26, 7035&#x2013;7045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673923</ArticleId><ArticleId IdType="pubmed">16807333</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Gopalakrishnan SM, Bui MH, Soni NB, Warrior U, Johnson EF, Donnelly JB, and Glaser KB (2011). 1-Benzyl-3-cetyl-2-methylimida-zolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. J. Biol. Chem 286, 43951&#x2013;43958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243513</ArticleId><ArticleId IdType="pubmed">22020937</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung WD, Sakabe K, Housley MP, Dias WB, and Hart GW (2008). O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins.J. Biol. Chem 283, 33935&#x2013;33941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2590692</ArticleId><ArticleId IdType="pubmed">18840611</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Dominguez M, Puri V, Sharma DK, Narita K, Wheatley CL, Marks DL, and Pargano RE (2002). Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest 109, 1541&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151017</ArticleId><ArticleId IdType="pubmed">12070301</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung JY, Steen JA, and Schwarz TL (2016). Phosphorylation-Induced Motor Shedding Is Required at Mitosis for Proper Distribution and Passive In-heritance of Mitochondria. Cell Rep. 16, 2142&#x2013;2155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001922</ArticleId><ArticleId IdType="pubmed">27524620</ArticleId></ArticleIdList></Reference><Reference><Citation>Courchet J, Lewis TL Jr., Lee S, Courchet V, Liou DY, Aizawa S, and Polleux F (2013). Terminal axon branching is regulated by the LKB1-NUAK1 kinase pathway via presynaptic mitochondrial capture. Cell 153, 1510&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3729210</ArticleId><ArticleId IdType="pubmed">23791179</ArticleId></ArticleIdList></Reference><Reference><Citation>Devkota AK, Tavares CD, Warthaka M, Abramczyk O, Marshall KD, Kaoud TS, Gorgulu K, Ozpolat B, and Dalby KN (2012). Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact. Biochemistry 51, 2100&#x2013;2112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3673019</ArticleId><ArticleId IdType="pubmed">22352903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezaki J, Takeda-Ezaki M, and Kominami E (2000). Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosisgene product, initiatesthe lysosomal degradation of subunit c of ATP synthase. J. Biochem 128, 509&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">10965052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gegg ME, and Schapira AHV (2018). The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J. 285, 3591&#x2013;3603.</Citation><ArticleIdList><ArticleId IdType="pubmed">29385658</ArticleId></ArticleIdList></Reference><Reference><Citation>Geier E, Pfeifer G, Wilm M, Lucchiari-Hartz M, Baumeister W, Eichmann K, and Niedermann G (1999). A giant protease with potential to substitute for some functions of the proteasome. Science 283, 978&#x2013;981.</Citation><ArticleIdList><ArticleId IdType="pubmed">9974389</ArticleId></ArticleIdList></Reference><Reference><Citation>Glater EE, Megeath LJ, Stowers RS, and Schwarz TL (2006). Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J. Cell Biol 173, 545&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2063864</ArticleId><ArticleId IdType="pubmed">16717129</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Macleod GT, Wellington A, Hu F, Panchumarthi S, Schoenfield M, Marin L, Charlton MP, Atwood HL, and Zinsmaier KE (2005). The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47, 379&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055062</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwee SSL, Radford RAW, Chow S, Syal MD, Morsch M, Formella I, Lee A, Don EK, Badrock AP, Cole NJ, et al. (2018). Aurora kinase B regulates axonal outgrowth and regeneration in thespinal motor neurons of developing zebrafish. Cell. Mol. Life Sci 75, 4269&#x2013;4285.</Citation><ArticleIdList><ArticleId IdType="pubmed">29468257</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrill JA, Chen H, Streifel KM, Yang D, Mundy WR, and Lein PJ (2015). Ontogeny of biochemical, morphological and functional parameters of synaptogenesis in primarycultures of rat hippocampal and cortical neurons. Mol. Brain 8, 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4339650</ArticleId><ArticleId IdType="pubmed">25757474</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, Heckel A, van Meel J, Rieder CL, and Peters JM (2003). The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol 161, 281&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2172906</ArticleId><ArticleId IdType="pubmed">12707311</ArticleId></ArticleIdList></Reference><Reference><Citation>Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, and Jaenisch R (2008). A drug-inducible system for direct reproramming of human somatic cells to pluripotency. Cell Stem Cell 3, 346&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4097107</ArticleId><ArticleId IdType="pubmed">18786421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CH, Shaltouki A, Gonzalez AE, Bettencourt da Cruz A, Burbulla LF, St Lawrence E, Schule B, Krainc D, Palmer TD, and Wang X (2016). Functional Impairment in Miro Degradation and Mitophagy IsaShared Feature in Familial and Sporadic Parkinson&#x2019;s Disease. Cell Stem Cell 19, 709&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5135570</ArticleId><ArticleId IdType="pubmed">27618216</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer SP, and Hart GW (2003). Roles ofthe tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity. J. Biol. Chem 278,24608&#x2013;24616.</Citation><ArticleIdList><ArticleId IdType="pubmed">12724313</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaqaman K, and Danuser G (2009). Computational image analysisofcellular dynamics: a case study based on particle tracking. Cold Spring Harb. Protoc 2009, pdb.top65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3155779</ArticleId><ArticleId IdType="pubmed">20150102</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaqaman K, Loerke D, Mettlen M, Kuwata H, Grinstein S, Schmid SL, and Danuser G (2008). Robust single-particle tracking in live-cell time-lapse sequences. Nat. Methods 5, 695&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2747604</ArticleId><ArticleId IdType="pubmed">18641657</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson LA, Moon KE, and Eisenberg M (1988). Inactivation of chymotrypsin and human skin chymase: kinetics of time-dependent inhibition in the presence of substrate. Biochim. Biophys. Acta 953, 269&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">2451541</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan MA, and Wilson L (2004). Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">15057285</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi DC, Zhang CL, Lin TM, Gusain A, Harris MG, Tree E, Yin Y, Wu C, Sheng ZH, Dempsey RJ, et al. (2015). Deletion of mitochondrial anchoring protects dysmyelinating shiverer: implications for progressive MS. J. Neurosci 35, 5293&#x2013;5306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4381002</ArticleId><ArticleId IdType="pubmed">25834054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J-S, Tian J-H, Pan P-Y, Zald P, Li C, Deng C, and Sheng Z-H (2008). Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell 132, 137&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2259239</ArticleId><ArticleId IdType="pubmed">18191227</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, Han S, Peng T, Thams S, Mikkilineni S, et al. (2014). Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14, 781&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruppa AJ, Kishi-Itakura C, Masters TA, Rorbach JE, Grice GL, Kendrick-Jones J, Nathan JA, Minczuk M, and Buss F (2018). Myosin VI-Dependent Actin Cages Encapsulate Parkin-Positive Damaged Mitochondria. Dev. Cell 44, 484&#x2013;499.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5932465</ArticleId><ArticleId IdType="pubmed">29398621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis TL Jr., Turi GF, Kwon SK, Losonczy A, and Polleux F (2016). Progressive Decrease of Mitochondrial Motility during Maturation of Cortical Axons In Vitro and In Vivo. Curr. Biol 26, 2602&#x2013;2608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5235338</ArticleId><ArticleId IdType="pubmed">27641765</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Lim S, Hoffman D, Aspenstrom P, Federoff HJ, and Rempe DA (2009). HUMMR, a hypoxia- and HIF-1alpha-inducible protein, alters mitochondrial distribution and transport. J. Cell Biol 185, 1065&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2711615</ArticleId><ArticleId IdType="pubmed">19528298</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Ac&#xed;n-Per&#xe9;z R, Geghman KD, Manfredi G, Lu B, and Li C (2011). Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc. Natl. Acad. Sci. USA 108, 12920&#x2013;12924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150934</ArticleId><ArticleId IdType="pubmed">21768365</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Dom&#xe9;nech G, Serrat R, Mirra S, D&#x2019;Aniello S, Somorjai I, Abad A, Vitureira N, Garc&#xed;a-Arum&#xed; E, Alonso MT, Rodriguez-Prados M, et al. (2012). The Eutherian Armcx genes regulate mitochondrial trafficking in neurons and interact with Miro and Trak2. Nat. Commun 3, 814.</Citation><ArticleIdList><ArticleId IdType="pubmed">22569362</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Dom&#xe9;nech G, Covill-Cooke C, Ivankovic D, Halff EF, Sheehan DF, Norkett R, Birsa N, and Kittler JT (2018). Miro proteins coordinate microtubule- and actin-dependent mitochondrial transport and distribution. EMBO J. 37, 321&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793800</ArticleId><ArticleId IdType="pubmed">29311115</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnaghi P, D&#x2019;Alessio R, Valsasina B, Avanzi N, Rizzi S, Asa D, Gasparri F, Cozzi L, Cucchi U, Orrenius C, et al. (2013). Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat. Chem. Biol 9, 548&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">23892893</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgeld T, and Schwarz TL (2017). Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture. Neuron 96, 651&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5687842</ArticleId><ArticleId IdType="pubmed">29096078</ArticleId></ArticleIdList></Reference><Reference><Citation>Misko A, Jiang S,Wegorzewska I, Milbrandt J, and Baloh RH (2010). Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J. Neurosci 30, 4232&#x2013;4240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852190</ArticleId><ArticleId IdType="pubmed">20335458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng JM, Chen MJ, Leung JY, Peng ZF, Manikandan J, Qi RZ, Chuah MI, West AK, Vickers JC, Lu J, et al. (2012). Transcriptional insights on the regenerative mechanics of axotomized neurons in vitro. J. Cell. Mol. Med 16, 789&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3822849</ArticleId><ArticleId IdType="pubmed">21711447</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak D, Sepp KJ, and Hollenbeck PJ (2010). Evidence that myosin activity opposes microtubule-based axonal transport of mitochondria. J. Neurosci 30, 8984&#x2013;8992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904968</ArticleId><ArticleId IdType="pubmed">20592219</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekkurnaz G, Trinidad JC, Wang X, Kong D, and Schwarz TL (2014). Glucose regulates mitochondrial motility via Milton modification by O-GlcNAc transferase. Cell 158, 54&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4224014</ArticleId><ArticleId IdType="pubmed">24995978</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, and Altschuler SJ (2004). Multidimensional drug profiling by automated microscopy. Science 306, 1194&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">15539606</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. (2014). R: A language en environment for statistical computing. R Foundation for Statistical Computing;  (Vienna, Austria: ). http://www.R-project.org.</Citation></Reference><Reference><Citation>Rose C,Vargas F, Facchinetti P, Bourgeat P, Bambal RB, Bishop PB, Chan SM, Moore AN, Ganellin CR, and Schwartz JC (1996). Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. Nature 380,403&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">8602240</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo GJ, Louie K, Wellington A, Macleod GT, Hu F, Panchumarthi S, and Zinsmaier KE (2009). Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport. J. Neurosci 20, 5443&#x2013;5455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693725</ArticleId><ArticleId IdType="pubmed">19403812</ArticleId></ArticleIdList></Reference><Reference><Citation>Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, Rizzuto R, and Hajnoczky G (2008). Bidirectional Ca2+-dependent control ofmitochondrial dynamics bythe Miro GTPase. Proc. Natl. Acad. Sci. USA 105,20728&#x2013;20733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634948</ArticleId><ArticleId IdType="pubmed">19098100</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton WM, and Hollenbeck PJ (2012). The axonal transport of mitochondria. J. Cell Sci 125, 2095&#x2013;2104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656622</ArticleId><ArticleId IdType="pubmed">22619228</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine Y, Lin-Moore A, Chenette DM, Wang X, Jiang Z, Cafferty WB, Hammarlund M, and Strittmatter SM (2018). Functional Genome-wide Screen Identifies Pathways Restricting Central Nervous System Axonal Regeneration. Cell Rep. 24, 269.</Citation><ArticleIdList><ArticleId IdType="pubmed">29972787</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, and Eliceiri KW (2012). NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlevkov E, Kramer T, Schapansky J, LaVoie MJ, and Schwarz TL (2016). Miro phosphorylation sites regulate Parkin recruitment and mitochondrial motility. Proc. Natl. Acad. Sci. USA 113, E6097&#x2013;E6106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5068282</ArticleId><ArticleId IdType="pubmed">27679849</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorbara CD, Wagner NE, Ladwig A, Nikic I, Merkler D, Kleele T, Marinkovic P, Naumann R, Godinho L, Bareyre FM, et al. (2014). Pervasive axonal transport deficits in multiple sclerosis models. Neuron 84, 1183&#x2013;1190.</Citation><ArticleIdList><ArticleId IdType="pubmed">25433639</ArticleId></ArticleIdList></Reference><Reference><Citation>Spence EF, and Soderling SH (2015). Actin Out: Regulation ofthe Synaptic Cytoskeleton. J. Biol. Chem 290, 28613&#x2013;28622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4661376</ArticleId><ArticleId IdType="pubmed">26453304</ArticleId></ArticleIdList></Reference><Reference><Citation>Stowers RS, Megeath LJ, Gorska-Andrzejak J, Meinertzhagen IA, and Schwarz TL (2002). Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36, 1063&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">12495622</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, and Youle RJ (2010). Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol 191, 1367&#x2013;1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3010068</ArticleId><ArticleId IdType="pubmed">21173115</ArticleId></ArticleIdList></Reference><Reference><Citation>Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, SOhof TC, and Wernig M (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2829121</ArticleId><ArticleId IdType="pubmed">20107439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SS, Sandoe J, Perez NP, Williams LA, Lee S, Boulting G, et al. (2014). Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 7,1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, and Schwarz TL (2009a). Imaging axonal transport of mitochondria. Methods Enzymol. 457, 319&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996865</ArticleId><ArticleId IdType="pubmed">19426876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, and Schwarz TL (2009b). The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility. Cell 136, 163&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768392</ArticleId><ArticleId IdType="pubmed">19135897</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, Rice S, Steen J, LaVoie MJ, and Schwarz TL (2011). PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3261796</ArticleId><ArticleId IdType="pubmed">22078885</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihofen A, Thomas KJ, Ostaszewski BL, Cookson MR, and Selkoe DJ (2009). Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 48, 2045&#x2013;2052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693257</ArticleId><ArticleId IdType="pubmed">19152501</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K, Zhong G, and Zhuang X (2013). Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons. Science 339, 452&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3815867</ArticleId><ArticleId IdType="pubmed">23239625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Ikezoe T, Nishioka C, Tasaka T, Taniguchi A, Kuwayama Y, Komatsu N, Bandobashi K, Togitani K, Koeffler HP, et al. (2007). AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 110, 2034&#x2013;2040.</Citation><ArticleIdList><ArticleId IdType="pubmed">17495131</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi M, Weaver D, and Hajnoczky G (2004). Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit. J. Cell Biol 167, 661&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2172592</ArticleId><ArticleId IdType="pubmed">15545319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J, et al. (2013). Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3751803</ArticleId><ArticleId IdType="pubmed">23764284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu YB, and Sheng ZH (2011). Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice. J. Biol. Chem 286, 23432&#x2013;23440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3123107</ArticleId><ArticleId IdType="pubmed">21518771</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>